Current Neuro-Oncology

Volume 25 Number 13
15 July 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 13, 15 July

Chatha G, Dhaliwal T, Castle-Kirszbaum MD, Amukotuwa S, Lai L, Kwan E.
The utility of arterial spin labelled perfusion-weighted magnetic resonance imaging in measuring the vascularity of high grade gliomas - A prospective study.
Heliyon. 2023 Jul 3;9(7):e17615. doi: 10.1016/j.heliyon.2023.e17615. PMID: 37519684. Observational study. ˍ

Hung ND, Dung LV, Vi NH, Hai Anh NT, Hong Phuong LT, Hieu ND, Duc NM.
The role of 3-Tesla magnetic resonance perfusion and spectroscopy in distinguishing glioblastoma from solitary brain metastasis.
J Clin Imaging Sci. 2023 Jul 3;13:19. doi: 10.25259/JCIS_49_2023. PMID: 37559877. Observational study. ˍ

Martínez Camblor L, Peña Suárez JM, Martínez-Cachero García M, Santamarta Liébana E, Rodríguez Castro J, Saiz Ayala A.
Cerebral microbleeds. Utility of SWI sequences.
Radiologia (Engl Ed). 2023 Jul 3;65(4):362-375. doi: 10.1016/j.rxeng.2022.12.006. PMID: 37516489. Observational study˰ ˍ


Takahashi S, Miyake K, Ogawa D, Anada M, Kinoshita T, Nishide T, Shibata T.
A Prospective Study of Intensity-modulated Radiation Therapy Using a Standard Radiation Dose for High-grade Glioma.
Cancer Diagn Progn. 2023 Jul 3;3(4):491-497. doi: 10.21873/cdp.10245. PMID: 37405214. Interventional study. ˍ

Tanrıkulu B, Yaşar AH, Canpolat C, Çorapçıoğlu F, Tezcanli E, Abacioglu U, Danyeli AE, Özek MM.
Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas.
J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04347-x. PMID: 37402093. Observational study˰ ˍ

Zhou Z, Yuan J, Chen H, Zhan LP, Sun EY, Chen B.
Prognostic nomogram for glioblastoma (GBM) patients presenting with distant extension: a seer-based study.
J Cancer Res Clin Oncol. 2023 Jul 4. doi: 10.1007/s00432-023-05049-7. PMID: 37401940. Observational study˰ ˍ


Guo X, Gu L, Li Y, Zheng Z, Chen W, Wang Y, Wang Y, Xing H, Shi Y, Liu D, Yang T, Xia Y, Li J, Wu J, Zhang K, Liang T, Wang H, Liu Q, Jin S, Qu T, Guo S, Li H, Wang Y, Ma W.
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors.
Front Oncol. 2023 Jul 6;13:1200815. doi: 10.3389/fonc.2023.1200815. PMID: 37483487. Observational study. ˍ

Kouli O, McLoone P, Morrison D, Zaorsky NG, Chalmers AJ.
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours.
Clin Transl Radiat Oncol. 2023 Jul 6;42:100658. doi: 10.1016/j.ctro.2023.100658. PMID: 37502698. Observational study. ˍ

Yin J, Yin W, Zheng L, Li Y, Luo C, Zhang S, Duan L, Zhou H, Cheng K, Lang J, Xu K.
Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study.
Clin Med Insights Oncol. 2023 Jul 6;17:11795549231175714. doi: 10.1177/11795549231175714. PMID: 37435019. Observational study. ˍ

Adhikari S, Bhutada AS, Ladner L, Cuoco JA, Entwistle JJ, Marvin EA, Rogers CM.
Prognostic indicators for H3K27M-mutant diffuse midline glioma: a population-based retrospective Surveillance, Epidemiology, and End Results database analysis.
World Neurosurg. 2023 Jul 7:S1878-8750(23)00930-0. doi: 10.1016/j.wneu.2023.07.001. PMID: 37423332. Observational study˰ ˍ

Chicard M, Iddir Y, Masliah Planchon J, Combaret V, Attignon V, Saint-Charles A, Frappaz D, Faure-Conter C, Beccaria K, Varlet P, Geoerger B, Baulande S, Pierron G, Bouchoucha Y, Doz F, Delattre O, Waterfall JJ, Bourdeaut F, Schleiermacher G.
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.
Cancers (Basel). 2023 Jul 7;15(13):3532. doi: 10.3390/cancers15133532. PMID: 37444642. Observational study. ˍ

Di Carlo D, Annereau M, Yoldjian I, Vassal G, Grill J.
An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking.
Ann Oncol. 2023 Jul 7:S0923-7534(23)00761-5. doi: 10.1016/j.annonc.2023.06.012. PMID: 37423297. Expanded access study˰ ˍ

Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M, Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J, Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Emmanuelle UC, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M, Olivier P, Delord JP, Cohen-Jonathan-Moyal E.
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Neuro Oncol. 2023 Jul 7:noad119. doi: 10.1093/neuonc/noad119. PMID: 37417948. Interventional study˰ ˍ

Muthukrishnan SD, Qi H, Wang D, Elahi L, Pham A, Alvarado AG, Li T, Gao F, Kawaguchi R, Lai A, Kornblum HI.
Low- and high-grade glioma endothelial cells differentially regulate tumor growth.
bioRxiv [Preprint]. 2023 Jul 7:2023.07.07.548125. doi: 10.1101/2023.07.07.548125. PMID: 37461434. Laboratory investigation. ˍ

Natukka T, Haapasalo J, Kivioja T, Rajala L, Raitanen J, Nevalainen J, Lahtela SL, Nordfors K, Rauhala M, Jukkola A, Frösen J, Helén P, Auvinen A, Haapasalo H.
Impact of timing of surgery and adjuvant treatment on survival of adult IDH-wildtype glioblastoma: a single-center study of 392 patients.
World Neurosurg. 2023 Jul 7:S1878-8750(23)00933-6. doi: 10.1016/j.wneu.2023.07.008. PMID: 37423335. Observational study. ˍ

Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, Ramakrishnan A, Shen L, Tsankov AM, Hambardzumyan D, Friedel RH, Zou H.
Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression.
Immunity. 2023 Jul 7:S1074-7613(23)00274-1. doi: 10.1016/j.immuni.2023.06.017. PMID: 37451265. Laboratory investigation˰ ˍ

Trivedi AG, Ramesh KK, Huang V, Mellon EA, Barker PB, Kleinberg LR, Weinberg BD, Shu HG, Shim H.
Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial.
Cancers (Basel). 2023 Jul 7;15(13):3524. doi: 10.3390/cancers15133524. PMID: 37444634. Observational study. ˍ

Ye Kahng J, Kang BH, Lee ST, Hong Choi S, Min Kim T, Park CK, Won JK, Park SH, Son J, Ho Lee J.
Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma.
Radiother Oncol. 2023 Jul 7:109800. doi: 10.1016/j.radonc.2023.109800. PMID: 37423479. Observational study˰ ˍ

Hönikl LS, Lange N, Meyer B, Gempt J, Meyer HS.
Postoperative Communicating Hydrocephalus Following Grade 2/3 Glioma Resection: Incidence, Timing and Risk Factors.
Cancers (Basel). 2023 Jul 9;15(14):3548. doi: 10.3390/cancers15143548. PMID: 37509211. Observational study. ˍ


Baviskar Y, Likonda B, Pant S, Mokal S, Pawar A, Dasgupta A, Chatterjee A, Gupta T.
Short-course Palliative Hypofractionated Radiotherapy in Patients with Poor-prognosis High-grade Glioma: Survival and Quality of Life Outcomes from a Prospective Phase II Study.
Clin Oncol (R Coll Radiol). 2023 Jul 10:S0936-6555(23)00240-6. doi: 10.1016/j.clon.2023.07.001. PMID: 37455146. Interventional study˰ ˍ


Halaj M, Kalita O, Tuckova L, Hrabalek L, Dolezel M, Vrbkova J.
Life expectancy in glioblastoma patients who had undergone stereotactic biopsy: a retrospective single-center study.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Jul 10. doi: 10.5507/bp.2023.030. PMID: 37431620. Observational study. ˍ

Otsuji R, Hata N, Funakoshi Y, Kuga D, Togao O, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Sako A, Kikuchi K, Yoshitake T, Yamamoto H, Mizoguchi M, Yoshimoto K.
Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study.
Neurol Med Chir (Tokyo). 2023 Jul 10. doi: 10.2176/jns-nmc.2022-0351. PMID: 37423755. Observational study. ˍ

Scheer M, Spindler K, Strauss C, Schob S, Dietzel CT, Leisz S, Prell J, Rampp S.
Surgical Site Infections in Glioblastoma Patients-A Retrospective Analysis.
J Pers Med. 2023 Jul 10;13(7):1117. doi: 10.3390/jpm13071117. PMID: 37511730. Observational study. ˍ

Liu X, Wang Y, Wang Y, Zhao J, Shi W, Zhao Y, Chen L, Wu L.
Associations between adiposity, diabetes, lifestyle factors and the risk of gliomas.
Front Med (Lausanne). 2023 Jul 11;10:1207223. doi: 10.3389/fmed.2023.1207223. PMID: 37497279. Observational study. ˍ

Zhang Z, Wu Y, Zhao X, Zhou J, Li L, Zhai X, Liang P.
The insertion and management of an external ventricular drain in pediatric patients with hydrocephalus associated with medulloblastoma.
Neurosurg Rev. 2023 Jul 11;46(1):170. doi: 10.1007/s10143-023-02080-7. PMID: 37433938. Observational study˰ ˍ


Currie S, Fatania K, Frood R, Whitehead R, Start J, Lee MT, McDonald B, Rankeillor K, Roberts P, Chakrabarty A, Mathew RK, Murray L, Short S, Scarsbrook A.
Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study.
Curr Oncol. 2023 Jul 13;30(7):6682-6698. doi: 10.3390/curroncol30070490. PMID: 37504350. Observational study. ˍ

Ilic I, Ilic M.
International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease.
Heliyon. 2023 Jul 13;9(7):e18222. doi: 10.1016/j.heliyon.2023.e18222. PMID: 37519769. Observational study. ˍ

Matsui JK, Allen PK, Perlow HK, Johnson JM, Paulino AC, McAleer MF, Fouladi M, Grosshans DR, Ghia AJ, Li J, Zaky WT, Chintagumpala MM, Palmer JD, McGovern SL.
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04386-4. PMID: 37440097. Observational study˰ ˍ


Somlyai G, Kovács BZ, Papp A, Somlyai I.
A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy.
Biomedicines. 2023 Jul 13;11(7):1989. doi: 10.3390/biomedicines11071989. PMID: 37509628. Observational study. ˍ

Ballal S, Yadav MP, Raju S, Roesch F, Martin M, Tripathi M, Bal C.
[177Lu]Lu-DOTAGA.Glu.(FAPi)2 Radionuclide Therapy: a New Treatment Option for Patients with Glioblastoma Multiforme.
Nucl Med Mol Imaging. 2023 Jul 14;58(1):32-34. doi: 10.1007/s13139-023-00814-5?. PMID: 38261876. Case report˰ ˍ

Bao Z, Li S, Wang L, Zhang B, Zhang P, Shi H, Qiu X, Jiang T.
PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial.
Chin Neurosurg J. 2023 Jul 14;9(1):21. doi: 10.1186/s41016-023-00329-0. PMID: 37443050. Interventional study protocol. ˍ

Kang HJ, Kim M, Kwak YK, Shin J, Lee SJ.
Reduced volume intensity-modulated radiotherapy with simultaneous integrated boost for patients with high-grade glioma: A retrospective observational study.
Medicine (Baltimore). 2023 Jul 14;102(28):e33955. doi: 10.1097/MD.0000000000033955?. PMID: 37443476. Observational study. ˍ

Cao W, Xiong L, Meng L, Li Z, Hu Z, Lei H, Wu J, Song T, Liu C, Wei R, Shen L, Hong J.
Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma.
Heliyon. 2023 Jul 15;9(7):e18310. doi: 10.1016/j.heliyon.2023.e18310. PMID: 37519736. Observational study. ˍ

Mallick S, Gupta S, Amariyil A, Kunhiparambath H, Laviraj MA, Sharma S, Sagiraju HKR, Julka PK, Sharma D, Rath GK.
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.
J Neurooncol. 2023 Jul 15. doi: 10.1007/s11060-023-04391-7. PMID: 37452916. Interventional study˰ ˍ